Kissei Pharmaceutical Co., Ltd.
 
 
 
 
公司概覽
業務類別 --
業務概覽 Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
公司地址 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
電話號碼 +81 263259081
傳真號碼 +81 263257899
公司網頁 http://www.kissei.co.jp
員工數量 2076
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Mutsuo Kanzawa Chairman of the Board and Chief Executive Officer -- 24/06/2025
Mr. Keiji Fukushima Director and Executive Vice President -- 24/06/2025
Mr. Yasuo Takehana Director, President and Chief Operating Officer -- 24/06/2025
Mr. Tetsu Takayama Director, Senior Managing Director and Chief Human Resources Officer -- 24/06/2025
Mr. Takahide Kitahara Director, Chief Financial Officer and Managing Director -- 24/06/2025
Mr. Hiroshi Noake Director and Head, Pharmaceutical Sales Division -- 24/06/2025
Mr. Keiji Miyazawa Director and Director, Research Division -- 24/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Mutsuo Kanzawa Chairman of the Board and Chief Executive Officer 24/06/2025
Mr. Yoshio Furihata Director 24/06/2025
Mr. Keiji Fukushima Director and Executive Vice President 24/06/2025
Mr. Yasuo Takehana Director, President and Chief Operating Officer 24/06/2025
Mr. Tetsu Takayama Director, Senior Managing Director and Chief Human Resources Officer 24/06/2025
Mr. Takahide Kitahara Director, Chief Financial Officer and Managing Director 24/06/2025
Mr. Shigetaka Shimizu Independent Director 24/06/2025
Mr. Minoru Nomura Independent Director 24/06/2025
Ms. Sayuri Uchikawa Independent Director 24/06/2025
Mr. Hiroshi Noake Director and Head, Pharmaceutical Sales Division 24/06/2025
Mr. Keiji Miyazawa Director and Director, Research Division 24/06/2025
Mr. Yoshinori Otsuki Independent Director 24/06/2025
 
所屬ETF (更新日期: 07/03/2026 04:22)
代號 名稱 佔比% 持有日期
IEFAiShares Core MSCI EAFE ETF0.40%28/02/2026
SCZiShares MSCI EAFE Small-Cap ETF0.25%28/02/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.19%28/02/2026
VIGIVanguard Intl Div Apprec ETF0.18%31/01/2026
SCHCSchwab International Small-Cap Eq ETF™0.16%28/02/2026
IDEViShares Core MSCI Intl Dev Mkts ETF0.07%28/02/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.06%27/02/2026
VTVanguard Total World Stock ETF0.05%31/01/2026
ISVLiShares Intl Dev Sm Cp Val Fctr ETF0.03%28/02/2026
IPACiShares Core MSCI Pacific ETF0.02%28/02/2026
VSGXVanguard ESG International Stock ETF0.01%31/01/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.01%24/02/2026
SCJiShares MSCI Japan Small-Cap ETF0.01%28/02/2026
ISCFiShares MSCI Intl Small-Cap Mltfct ETF0.01%28/02/2026
AVDSAvantis International Small Cp Eq ETF0.01%28/02/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.003%27/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
AVDEAvantis International Equity ETF<0.000001%26/07/2025
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.